Agenda

Tuesday, Sep 3 Wednesday, Sep 4

Tuesday, September 3, 2024

KEYNOTE SPEAKER

INTRODUCTION - PAMELA SCHWARTZBERG (NIAID)

09:00 am - 09:45 am EST
Between innate and adaptive immunity: innate-like T cells

Mitchell Kronenberg, Ph.D.

La Jolla Institute of Immunology

HONORING JAY BERZOFSKY

SESSION CHAIRS - TIM GRETEN (NCI) AND WARREN STROBER (NIAID)

09:45 am - 09:55 am EST
Introduction of Jay Berzofsky
09:55 am - 10:20 am EST
The Two-Faced Epitope: Discovering Tolerogenic Epitopes in Silico and In Vivo

Annie De Groot, MD

Epivax

10:20 am - 10:45 am EST
Myeloid cell biology in the context of vaccines

Dmitry Gabrilovich, MD, Ph.D.

Astra-Zeneka

10:45 am - 10:55 am EST
Jay Berzofsky's Response

Jay Berzofsky, M.D., Ph.D.

NCI

10:55 am - 11:15 am EST

Coffee Break

EMERGING VACCINE DEVELOPMENTS

SESSION CHAIRS - DANIELA VERTHELYI (FDA) AND GREGOIRE ALTAN-BONNET (NCI)

11:15 am - 11:40 am EST
mRNA vaccine Design to Target Cellular Immunity

Asaf Poran, Ph.D.

BioNTech

11:40 am - 12:05 pm EST
Advances in Cancer Vaccine Development

Bob Seder, M.D.

NIAID/VRC

12:05 pm - 12:15 pm EST
SARS-CoV-2 mRNA vaccination/infection elicit pharyngeal mucosal B cell immunity

Kalpana Manthiram

NIAID

12:15 pm - 01:15 pm EST

Lunch Break

01:15 pm - 02:15 pm EST

Poster Session

CANCER IMMUNOTHERAPY

SESSION CHAIRS - JOANNA BANDOLA-SIMON (NCI) AND LI YANG (NCI)

02:15 pm - 02:40 pm EST
Hematologic Malignancy Target Discovery

Art Shaffer, Ph.D.

Astra Zeneca

02:40 pm - 03:05 pm EST
CAR-Macrophages

Michael Kinchinsky, PHARMD, Ph.D.

Carisma therapeutics

03:05 pm - 03:25 pm EST

Coffee break 

03:25 pm - 03:50 pm EST
Myeloid cells in the tumor microenvironment

Leila Akkari, Ph.D.

Nederlands Kanker Institut

03:50 pm - 04:00 pm EST
Intravital Microscopy of Hepatic Tumors Reveals Local Restriction of Immune Cell Motility in Fatty Liver Disease

Olena Kamenyeva

NIAID

04:00 pm - 04:10 pm EST
Engineering CARs to ameliorate tonic signaling mediated T cell dysfunction

Pradip Bajgain

NCI

04:10 pm - 04:20 pm EST
Costimulation by Death Receptor 3 potentiates iNKT cell activation and anti-tumor activity

Nurcin Liman

NCI

Wednesday, September 4, 2024

ENVIRONMENTAL CUES AND IMMUNOREGULATION 

SESSION CHAIRS - MIA SUNG (NIA) AND MICHAEL SAK (NHLBI)

09:00 am - 09:25 am EST
Diet, microbiota and inflammation

Ivan Vujikovic Cvijin, Ph.D.

Cedar Sinai Medical Center

09:25 am - 09:50 am EST
High salt, inflammation and cardiovascular disease

Annet Kirabo, Ph.D.

Vanderbilt School of University

09:50 am - 10:15 am EST
T cell biology in aging

Janko Nikolich, MD, Ph.D

University of Arizona

10:15 am - 10:40 am EST
Safe starts: Strategies to protect newborns from influenza

Martha Alexander-Miller, Ph.D.

Wake Forest University School of Medicine

10:40 am - 11:00 am EST

Coffee break

11:00 am - 11:25 am EST
Cross-presentation by dendritic cells from live antigen-donor cells

Anne Hosmalin, Ph. D.

Institut Cochin

11:25 am - 11:35 am EST
Toxic cultures: E-cigarettes and the oral microbial exposome

Prem Prashant Chaudhary

(NIAID)

11:35 am - 11:45 am EST
Host-microbiota interaction is regulated by skin autonomous production of antibodies

Inta Gribonika

(NIAID)

NEURO-IMMUNE AXIS

SESSION CHAIRS - HAN-YU SHIH (NEI), HAO JIN (NIAID) AND MASAHI WATANABE (NCI)

11:45 am - 12:10 pm EST
Navigating turbulent neuroimmune waters

Jonathan Kipnis

Washington University in Saint Louis

12:10 pm - 12:35 pm EST
Protection of CNS barriers by humoral immunity

Dorian McGavern

NINDS

12:40 pm - 01:30 pm EST

Lunch Break

01:30 pm - 01:55 pm EST
Interaction network of brain cells and its dysregulation

Marco Colonna, MD

Washington University School of Medicine in St. Louis

01:55 pm - 02:05 pm EST
Gut microbiome and vagus nerve regulate liver cancer immunity

Kylynda Bauer

(NCI)

02:05 pm - 02:15 pm EST
Antigen-induced prevention/reversal of CNS inflammation in experimental demyelinating disease

Lixin Zheng

(NIAID)

ALLERGY AND AUTOIMMUNITY

SESSION CHAIRS - NAOMI TAYLOR (NCI) AND SAFARAZ HASNI (NIAMS)

02:15 pm - 02:40 pm EST
Therapeutic implications of fine tuning the actions of Yc family cytokines

Warren Leonard, MD

NHLBI

02:40 pm - 03:05 pm EST
New Frontiers in B-cell depletion: From Cancer to Systemic Autoimmune Diseases

Richard Siegel, MD, Ph.D.

Novartis

03:05 pm - 03:30 pm EST
Immunopathology of allergy and autoimmunity disorders

Joshua Milner, MD

Columbia University

03:30 pm - 03:50 pm EST

Coffee break

03:50 pm - 04:15 pm EST
The role of biomarkers in the clinical success of therapies for autoimmune disease

Aaron Winkler, Ph.D.

Pfizer

04:15 pm - 04:25 pm EST
NAD-boosting blunts Th17 immunity via arginine biosynthesis mediated signaling in psoriasis

Kim Han

(NHLBI)

04:25 pm - 04:35 pm EST
Commensal bacteria moderates ocular autoinflammation in the context of NLRP3 mutations

Mary Mattapallil

(NEI)